Robert Andrew  Douglas net worth and biography

Robert Douglas Biography and Net Worth

COO of ResMed
Robert Douglas was appointed ResMed’s president in March 2013 and chief operating officer in September 2011; together with ResMed chief executive officer, Mick Farrell, he holds full operational responsibility for ResMed and its subsidiaries.

Previously, Rob was ResMed’s chief operating officer of Asia Pacific and global supply chain from 2008 through 2011, responsible for the region’s commercial distribution, sales operations, and global manufacturing; Sydney chief operating officer from 2005 through 2008, responsible for the company’s manufacturing and research and development; vice president of operations from 2003 to 2005, responsible for the company’s manufacturing; vice president of ResMed’s respiratory and cardiac business from 2002 to 2003; and vice president of corporate marketing when he joined ResMed in 2001.

Rob serves on the board of directors of Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, since December 2019, and is a member of the Audit Committee. He also serves as co-vice chairman on the Board of Directors of the San Diego Regional Economic Development Corporation, as well as vice chairman on the Board of Directors of EvoNexus, a non-profit technology incubator.

Rob has a Master of Business Administration from Macquarie University, a bachelor’s in electrical engineering with first-class honors, and a Bachelor of Science in computer sciences from the University of New South Wales, Sydney.

What is Robert Andrew Douglas' net worth?

The estimated net worth of Robert Andrew Douglas is at least $53.01 million as of August 15th, 2023. Mr. Douglas owns 250,526 shares of ResMed stock worth more than $53,006,291 as of May 23rd. This net worth evaluation does not reflect any other assets that Mr. Douglas may own. Additionally, Mr. Douglas receives a salary of $1,910,000.00 as COO at ResMed. Learn More about Robert Andrew Douglas' net worth.

How old is Robert Andrew Douglas?

Mr. Douglas is currently 64 years old. There are 5 older executives and no younger executives at ResMed. The oldest executive at ResMed is Dr. Peter C. Farrell A.M., B.E., BE, who is 82 years old. Learn More on Robert Andrew Douglas' age.

What is Robert Andrew Douglas' salary?

As the COO of ResMed Inc., Mr. Douglas earns $1,910,000.00 per year. The highest earning executive at ResMed is Mr. Michael J. Farrell BE, MBA, SM, CEO & Chairman, who commands a salary of $2,870,000.00 per year. Learn More on Robert Andrew Douglas' salary.

How do I contact Robert Andrew Douglas?

The corporate mailing address for Mr. Douglas and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Robert Andrew Douglas' contact information.

Has Robert Andrew Douglas been buying or selling shares of ResMed?

Robert Andrew Douglas has not been actively trading shares of ResMed over the course of the past ninety days. Most recently, Robert Andrew Douglas sold 1,500 shares of the business's stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $181.01, for a transaction totalling $271,515.00. Following the completion of the sale, the chief operating officer now directly owns 250,526 shares of the company's stock, valued at $45,347,711.26. Learn More on Robert Andrew Douglas' trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 23 times. They sold a total of 70,837 shares worth more than $13,371,821.12. The most recent insider tranaction occured on May, 15th when Director Witte Jan De sold 360 shares worth more than $78,584.40. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 5/15/2024.

Robert Andrew Douglas Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/15/2023Sell1,500$181.01$271,515.00250,526View SEC Filing Icon  
7/17/2023Sell1,500$222.22$333,330.00252,026View SEC Filing Icon  
6/15/2023Sell1,500$216.27$324,405.00253,526View SEC Filing Icon  
5/15/2023Sell1,500$232.85$349,275.00255,026View SEC Filing Icon  
4/17/2023Sell1,500$224.65$336,975.00256,526View SEC Filing Icon  
3/15/2023Sell1,500$206.14$309,210.00258,026View SEC Filing Icon  
2/15/2023Sell1,500$213.50$320,250.00261,445View SEC Filing Icon  
1/17/2023Sell1,500$220.43$330,645.00226,208View SEC Filing Icon  
11/15/2022Sell11,280$222.07$2,504,949.6040,186View SEC Filing Icon  
10/14/2022Sell11,355$215.09$2,442,346.9535,086View SEC Filing Icon  
9/15/2022Sell11,189$232.51$2,601,554.3928,408View SEC Filing Icon  
4/18/2022Sell8,000$233.29$1,866,320.0017,175View SEC Filing Icon  
3/15/2022Sell8,000$238.07$1,904,560.00View SEC Filing Icon  
1/18/2022Sell8,000$247.80$1,982,400.00View SEC Filing Icon  
12/15/2021Sell8,000$256.52$2,052,160.00View SEC Filing Icon  
11/15/2021Sell8,000$271.75$2,174,000.00View SEC Filing Icon  
10/15/2021Sell8,000$255.77$2,046,160.00View SEC Filing Icon  
9/15/2021Sell8,000$291.83$2,334,640.00View SEC Filing Icon  
8/16/2021Sell8,000$275.57$2,204,560.0024,767View SEC Filing Icon  
7/15/2021Sell8,000$248.00$1,984,000.00View SEC Filing Icon  
7/15/2021Sell8,000$248.00$1,984,000.00View SEC Filing Icon  
5/17/2021Sell8,000$195.00$1,560,000.008,766View SEC Filing Icon  
4/15/2021Sell964$207.45$199,981.8016,701View SEC Filing Icon  
3/15/2021Sell1,081$185.48$200,503.8816,701View SEC Filing Icon  
1/15/2021Sell938$212.86$199,662.6812,602View SEC Filing Icon  
11/24/2020Sell955$211.00$201,505.0012,603View SEC Filing Icon  
10/15/2020Sell1,125$176.72$198,810.0024,620View SEC Filing Icon  
9/15/2020Sell1,147$175.49$201,287.0324,620View SEC Filing Icon  
7/15/2020Sell1,026$196.98$202,101.4824,620View SEC Filing Icon  
6/15/2020Sell1,245$158.79$197,693.5524,620View SEC Filing Icon  
4/15/2020Sell1,222$159.03$194,334.6624,544View SEC Filing Icon  
2/18/2020Sell1,133$176.14$199,566.6224,544View SEC Filing Icon  
1/15/2020Sell1,264$158.43$200,255.5266,671View SEC Filing Icon  
12/16/2019Sell1,302$154.71$201,432.4266,671View SEC Filing Icon  
11/18/2019Sell1,360$146.63$199,416.80
10/15/2019Sell3,302$130.25$430,085.5048,716View SEC Filing Icon  
9/16/2019Sell3,307$131.63$435,300.4148,721View SEC Filing Icon  
8/15/2019Sell4,070$131.12$533,658.4048,721View SEC Filing Icon  
7/15/2019Sell4,111$124.50$511,819.5048,721View SEC Filing Icon  
6/17/2019Sell4,154$118.44$491,999.7648,721View SEC Filing Icon  
5/15/2019Sell4,200$111.35$467,670.00View SEC Filing Icon  
4/15/2019Sell4,285$102.29$438,312.6548,604View SEC Filing Icon  
3/15/2019Sell4,298$100.90$433,668.2048,604View SEC Filing Icon  
2/15/2019Sell4,313$99.95$431,084.3541,728View SEC Filing Icon  
1/15/2019Sell4,188$114.18$478,185.8441,728View SEC Filing Icon  
12/17/2018Sell4,193$112.56$471,964.0889,605View SEC Filing Icon  
11/15/2018Sell3,307$101.44$335,462.0859,112View SEC Filing Icon  
1/4/2016Sell6,337$52.97$335,670.8931,304View SEC Filing Icon  
12/1/2015Sell6,333$59.77$378,523.4131,304View SEC Filing Icon  
11/2/2015Sell6,333$57.60$364,780.8068,391View SEC Filing Icon  
10/5/2015Sell6,333$52.13$330,139.2968,179View SEC Filing Icon  
9/3/2015Sell6,333$52.04$329,569.3275,316View SEC Filing Icon  
7/1/2015Sell6,333$56.59$358,384.47View SEC Filing Icon  
6/1/2015Sell6,333$59.22$375,040.26View SEC Filing Icon  
4/1/2015Sell6,333$70.67$447,553.11View SEC Filing Icon  
3/2/2015Sell6,333$64.39$407,781.87View SEC Filing Icon  
2/3/2015Sell6,333$62.35$394,862.55View SEC Filing Icon  
1/2/2015Sell8,000$56.99$455,920.00View SEC Filing Icon  
12/1/2014Sell8,000$52.93$423,440.00View SEC Filing Icon  
11/3/2014Sell8,000$51.84$414,720.00View SEC Filing Icon  
10/1/2014Sell8,000$49.11$392,880.00View SEC Filing Icon  
8/1/2014Sell8,000$48.95$391,600.00View SEC Filing Icon  
7/1/2014Sell8,000$50.11$400,880.00View SEC Filing Icon  
6/2/2014Sell8,000$50.11$400,880.00View SEC Filing Icon  
5/1/2014Sell8,000$49.75$398,000.00View SEC Filing Icon  
12/2/2013Sell8,000$49.10$392,800.00100,572View SEC Filing Icon  
10/1/2013Sell8,000$53.20$425,600.00View SEC Filing Icon  
9/3/2013Sell8,000$47.51$380,080.00123,892View SEC Filing Icon  
8/1/2013Sell8,000$48.57$388,560.00View SEC Filing Icon  
6/3/2013Sell8,000$47.96$383,680.00View SEC Filing Icon  
2/4/2013Sell8,000$44.14$353,120.00View SEC Filing Icon  
See Full Table

Robert Andrew Douglas Buying and Selling Activity at ResMed

This chart shows Robert Andrew Douglas's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $211.58
Low: $210.24
High: $218.10

50 Day Range

MA: $199.30
Low: $173.86
High: $220.63

2 Week Range

Now: $211.58
Low: $132.24
High: $229.97

Volume

1,032,673 shs

Average Volume

1,023,682 shs

Market Capitalization

$31.08 billion

P/E Ratio

32.50

Dividend Yield

0.88%

Beta

0.64